Abiopharma

Indaptus Therapeutics Announces Reverse Stock Split

Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements

Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders

New Form 8-K - BIOCRYST PHARMACEUTICALS INC Filed: 2025-06-25 AccNo: 0001171843-25-004091 Size: 188 KB Item 8.01: Other Events

New Form 6-K - Concord Medical Services Holdings Ltd Filed: 2025-06-25 AccNo: 0001104659-25-062341 Size: 10 KB

New Form 20-F - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-06-25 AccNo: 0001395064-25-000095 Size: 30 MB

General Announcement: Minutes of Annual General Meeting held on 29 May 2025

New Form 6-K - GSK plc Filed: 2025-06-25 AccNo: 0001654954-25-007374 Size: 1 MB

New Form 8-K - CorMedix Inc. Filed: 2025-06-25 AccNo: 0001213900-25-057451 Size: 196 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Strawberry Fields REIT, Inc. Filed: 2025-06-25 AccNo: 0001641172-25-016353 Size: 211 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - Haleon plc Filed: 2025-06-25 AccNo: 0001654954-25-007372 Size: 35 KB

New Form 6-K - Addex Therapeutics Ltd. Filed: 2025-06-25 AccNo: 0001171843-25-004087 Size: 13 KB

New Form 6-K - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-06-25 AccNo: 0001395064-25-000093 Size: 50 KB

New Form 4 - Ainos, Inc. Filed: 2025-06-25 AccNo: 0000950103-25-007790 Size: 6 KB

New Form 6-K - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-06-25 AccNo: 0001395064-25-000091 Size: 21 KB